Busulfan for the treatment of myeloproliferative neoplasms: the Mayo Clinic experience

K. Begna; A. Abdelatif; S. Schwager; C. Hanson; A. Pardanani; A. Tefferi

doi:10.1038/BCJ.2016.34

Busulfan for the treatment of myeloproliferative neoplasms: the Mayo Clinic experience

K. Begna, A. Abdelatif, S. Schwager, C. Hanson, A. Pardanani, A. Tefferi

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Article number	e427
Journal	Blood cancer journal
Volume	6
Issue number	5
DOIs	https://doi.org/10.1038/BCJ.2016.34
State	Published - 2016

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1038/BCJ.2016.34

Cite this

@article{7570e9faa0284f569510c992143521d9,

title = "Busulfan for the treatment of myeloproliferative neoplasms: the Mayo Clinic experience",

author = "K. Begna and A. Abdelatif and S. Schwager and C. Hanson and A. Pardanani and A. Tefferi",

year = "2016",

doi = "10.1038/BCJ.2016.34",

language = "English (US)",

volume = "6",

journal = "Blood cancer journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "5",

}

TY - JOUR

T1 - Busulfan for the treatment of myeloproliferative neoplasms

T2 - the Mayo Clinic experience

AU - Begna, K.

AU - Abdelatif, A.

AU - Schwager, S.

AU - Hanson, C.

AU - Pardanani, A.

AU - Tefferi, A.

PY - 2016

Y1 - 2016

UR - http://www.scopus.com/inward/record.url?scp=85013146447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013146447&partnerID=8YFLogxK

U2 - 10.1038/BCJ.2016.34

DO - 10.1038/BCJ.2016.34

M3 - Letter

C2 - 27232929

AN - SCOPUS:85013146447

SN - 2044-5385

VL - 6

JO - Blood cancer journal

JF - Blood cancer journal

IS - 5

M1 - e427

ER -

Busulfan for the treatment of myeloproliferative neoplasms: the Mayo Clinic experience

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this